#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3538998	A	Activity of human CYP2B6 assessed as enzyme-mediated compound formation treated with 10 uM ticlopidine for 60 mins by HPLC-MS analysis in presence of NADPH	Homo sapiens	5	ALA3525941	single protein format	Scientific Literature
2.	ALA3538999	A	Activity of rabbit CYP2B4 assessed as enzyme-mediated compound formation treated with 10 uM ticlopidine for 60 mins by HPLC-MS analysis in presence of NADPH	Oryctolagus cuniculus	5	ALA3525941	single protein format	Scientific Literature
3.	ALA3532675	A	Drug level in human liver microsomes assessed as compound formation treated with 10 uM ticlopidine for 60 mins by HPLC-MS analysis in presence of NADPH	Homo sapiens	5	ALA3525941	assay format	Scientific Literature
4.	ALA3532676	A	Activity of recombinant full-length CYP2B6 (unknown origin) expressed in baculovirus-infected insect cells assessed as enzyme-mediated compound formation treated with 10 uM ticlopidine for 60 mins by HPLC-MS analysis in presence of NADPH	Homo sapiens	5	ALA3525941	cell-based format	Scientific Literature
5.	ALA3535628	A	Activity of human CYP2B6 assessed as observed rate constant for enzyme-mediated compound formation treated with 1 uM ticlopidine by HPLC-MS analysis in presence of NADPH	Homo sapiens	5	ALA3525941	single protein format	Scientific Literature
6.	ALA3535629	A	Activity of rabbit CYP2B4 assessed as observed rate constant for enzyme-mediated compound formation treated with 1 uM ticlopidine by HPLC-MS analysis in presence of NADPH	Oryctolagus cuniculus	5	ALA3525941	single protein format	Scientific Literature
7.	ALA3535632	P	Retention time of the compound by HPLC-MS analysis		4	ALA3525941	small-molecule physicochemical format	Scientific Literature